Is Cancer a Disease of the Genome?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genes. The implications for therapy, as we match genetic understanding to drugs, may well be revolutionary. Dr. Gary Kohn hosts.
Overview
Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genes. The implications for therapy, as we match genetic understanding to drugs, may well be revolutionary. Dr. Gary Kohn hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?